These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9419755)

  • 1. Estrogen mustard induces cell cycle arrest of human epithelial ovarian cancer cell lines.
    Nathan JD; Keefe DL; Weinstein MA; Chen Z; Naftolin F
    J Soc Gynecol Investig; 1994; 1(1):97-103. PubMed ID: 9419755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis and suppression of clonogenicity of ovarian carcinoma cells with estrogen mustard.
    Chen Z; Fadiel A; Jia JF; Sakamoto H; Carbone R; Naftolin F
    Cancer; 1999 Jun; 85(12):2616-22. PubMed ID: 10375110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines.
    Bu SZ; Yin DL; Ren XH; Jiang LZ; Wu ZJ; Gao QR; Pei G
    Cancer; 1997 May; 79(10):1944-50. PubMed ID: 9149021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
    Speicher LA; Barone L; Tew KD
    Cancer Res; 1992 Aug; 52(16):4433-40. PubMed ID: 1353706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estramustine: a novel radiation enhancer in human carcinoma cells.
    Ryu S; Gabel M; Khil MS; Lee YJ; Kim SH; Kim JH
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):99-104. PubMed ID: 7916009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estramustine resistance.
    Sangrajrang S; Calvo F; Fellous A
    Gen Pharmacol; 1999 Aug; 33(2):107-13. PubMed ID: 10461848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
    Speicher LA; Sheridan VR; Godwin AK; Tew KD
    Br J Cancer; 1991 Aug; 64(2):267-73. PubMed ID: 1892755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
    Stearns ME; Wang M; Tew KD; Binder LI
    J Cell Biol; 1988 Dec; 107(6 Pt 2):2647-56. PubMed ID: 3060470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting microtubule-associated proteins in glioblastoma: a new strategy for selective therapy.
    Piepmeier JM; Pedersen PE; Yoshida D; Greer C
    Ann Surg Oncol; 1996 Nov; 3(6):543-9. PubMed ID: 8915486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
    Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
    Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
    Martínez J; Santibáñez JF; Vial C; Maccioni RB
    Mol Cell Biochem; 1992 Nov; 117(2):165-73. PubMed ID: 1488050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo.
    Bergenheim AT; Zackrisson B; Elfverson J; Roos G; Henriksson R
    J Neurooncol; 1995; 23(3):191-200. PubMed ID: 7673981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of GnRH agonist in epithelial ovarian cancer.
    Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE
    Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
    J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
    Mohan R; Panda D
    Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
    Rose FV; Barnea ER
    Oncogene; 1996 Mar; 12(5):999-1003. PubMed ID: 8649817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estramustine binds MAP-2 to inhibit microtubule assembly in vitro.
    Stearns ME; Tew KD
    J Cell Sci; 1988 Mar; 89 ( Pt 3)():331-42. PubMed ID: 3198696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
    Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
    J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.